Chronos Wealth Management LLC Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Chronos Wealth Management LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 17,537 shares of the healthcare conglomerate’s stock after buying an additional 28 shares during the quarter. UnitedHealth Group accounts for about 4.5% of Chronos Wealth Management LLC’s portfolio, making the stock its 9th biggest holding. Chronos Wealth Management LLC’s holdings in UnitedHealth Group were worth $8,871,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in UNH. AMF Tjanstepension AB raised its holdings in UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after acquiring an additional 121,180 shares in the last quarter. Hudson Value Partners LLC increased its holdings in UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after buying an additional 82 shares during the last quarter. Wealth Group Ltd. grew its position in shares of UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after acquiring an additional 68 shares during the period. Sendero Wealth Management LLC lifted its stake in UnitedHealth Group by 1.4% in the 3rd quarter. Sendero Wealth Management LLC now owns 2,692 shares of the healthcare conglomerate’s stock valued at $1,574,000 after purchasing an additional 37 shares during the last quarter. Finally, Tobam raised its stake in UnitedHealth Group by 22.7% in the third quarter. Tobam now owns 2,320 shares of the healthcare conglomerate’s stock valued at $1,356,000 after buying an additional 429 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Down 0.6 %

NYSE UNH opened at $526.68 on Friday. The stock has a market capitalization of $484.69 billion, a P/E ratio of 33.98, a P/E/G ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business has a 50 day simple moving average of $530.85 and a 200 day simple moving average of $564.52. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the business earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Bank of America cut their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.